Longboard pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4)

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to three new employees. the compensation committee of the board of directors of longboard approved the grants of non-qualified stock options to purchase an aggregate of 56,000 shares of its common stock (the “common stock”) and 35,000 restricted.
LBPH Ratings Summary
LBPH Quant Ranking